Safety and effectiveness of a GENOSS stent in multiple blocked arteries
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial tests a new drug-coated stent (GENOSS® DES) for people with blockages in multiple heart arteries. It aims to see how safe and effective the stent is for these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have coronary artery disease in more than one blood vessel (or a previous blockage that was treated)
- You received a GENOSS® drug-eluting stent during your angioplasty
- You agree to the study plan, follow-up visits, and sign a consent form
- If you are not a native Korean speaker, you must be fluent in Korean and understand Korean documents
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial tests whether a shorter course of dual antiplatelet therapy (two blood thinners) is safe and effective for people who have received a GENOSS stent for coronary artery disease. It aims to reduce the risk of bleeding while still preventing heart attacks.
This study tests whether taking two blood thinners for one year after getting a special GENOSS stent is safe and works well for people with coronary artery disease, especially if the stent placement was complex. The goal is to prevent blood clots and keep your artery open.
This study compares two ways to open blocked heart arteries: one uses a balloon coated with medicine, and the other uses a small mesh tube (stent) that releases medicine. The goal is to see which works better for people with chest pain or a recent heart attack.
This study compares two treatments for people with blockages in more than one heart artery. One treatment uses a drug-coated balloon to open the artery, and the other uses a drug-releasing stent. The goal is to see which approach is safer and works better.
This study looks at how well doctors can treat multiple blocked heart arteries using a specific drug-eluting stent, aiming to fully open them. It may help patients whose blockage pattern fits the study, but it does not include certain high-risk or special cases.
Hear when a new Percutaneous Coronary Intervention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.